Daniel no need to speculate I already asked that question about 6 months ago.
Their response was that they had put a stop to their current path as the thinking was that they may be on the wrong path and putting money into a treatment that may not give the company the best bang for the buck ( my words), and only target an outcome that was deemed appropriate to move forward and at that point Head and Neck Cancer was mentioned. So this midstream change in focus was always going to in the short term, delay the time line of HPV, as to partnerships I do remember Wayne in the AGM stating ongoing
talks and stating it is a long process however it was progressing. GLTA
- Forums
- ASX - By Stock
- AVR
- DNA vaccine encoding
DNA vaccine encoding, page-22
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.67 |
Change
-0.330(2.20%) |
Mkt cap ! $311.5M |
Open | High | Low | Value | Volume |
$15.00 | $15.00 | $14.50 | $44.10K | 3.006K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 150 | $14.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.67 | 184 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 150 | 14.360 |
1 | 60 | 14.350 |
1 | 200 | 14.300 |
1 | 38 | 14.260 |
1 | 200 | 14.200 |
Price($) | Vol. | No. |
---|---|---|
14.640 | 122 | 1 |
14.680 | 60 | 1 |
14.720 | 355 | 1 |
14.730 | 27 | 1 |
14.850 | 47 | 1 |
Last trade - 13.09pm 15/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online